|
FY2026
12 months to Jan 31, 2026
|
FY2025
12 months to Jan 31, 2025
|
FY2024
12 months to Jan 31, 2024
|
FY2023
12 months to Jan 31, 2023
|
FY2022
12 months to Jan 31, 2022
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net loss | |||||
| Adjustments to reconcile net income to net cash used in operating activities: | |||||
| Depreciation | |||||
| Impairment loss on software | |||||
| Impairment loss on goodwill | |||||
| Accounts payable written off | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Accounts payable and accrued liabilities | |||||
| Accrued interest | |||||
| Management salary payable | |||||
| Net cash used in operating activities | |||||
| Acquisitions of subsidiaries, net of cash acquired | |||||
| Purchase of plant and equipment | |||||
| Cash Flows from Investing Activities | |||||
| Cash Flows from Financing Activities | |||||
| Proceeds from issuance of convertible notes to non-affiliate | |||||
| Proceeds from related parties | |||||
| Repayment to related parties | |||||
| Proceeds from former director | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents - beginning of period | |||||
| Cash and cash equivalents - end of period | |||||
| Supplemental cash flow disclosures: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Debt forgiven by related party | |||||
Loading...